CS logo
small CS logo
Novant Health, Oncology Research Institute

Winston Salem, North Carolina, United States

About Novant Health, Oncology Research Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Novant Health, Oncology Research Institute


During the past decade, Novant Health, Oncology Research Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health, Oncology Research Institute" #1 collaborator was "ARMO BioSciences" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Novant Health, Oncology Research Institute


According to Clinical.Site data, the most researched conditions in "Novant Health, Oncology Research Institute" are "Breast Neoplasms" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Leukemia, B-cell" (1 trials), "Leukemia, Lymphocytic" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Novant Health, Oncology Research Institute" in a lesser frequency.

Clinical Trials Intervention Types at Novant Health, Oncology Research Institute


Most popular intervention types in "Novant Health, Oncology Research Institute" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (1 trials), "FOLFOX" (1 trials), "Fulvestrant" (1 trials), "Ibrutinib" (1 trials) and "Pegilodecakin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Novant Health, Oncology Research Institute


The vast majority of trials in "Novant Health, Oncology Research Institute" are 2 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Novant Health, Oncology Research Institute


Currently, there are NaN active trials in "Novant Health, Oncology Research Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Novant Health, Oncology Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Novant Health, Oncology Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".